Amal Moumen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Amal Moumen has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
A. Meftah
39 shared publicationsG. Belmejdoub
39 shared publicationsH. El Jadi
31 shared publicationsA.A. Guerboub
24 shared publicationsS. Elmoussaoui
Service d'endocrinologie et de diabétologie, Hôpital militaire d'instruction Mohammed V, Rabat, Maroc
21 shared publicationsJ. Issouani
19 shared publications
Latest Publications
- Open Access
- 31 July 2024
- Published by University of Toronto Libraries - UOTL in University of Toronto Medical Journal
- Vol. 101 (2)
Predicting malignancy of thyroid nodule using EU-TIRADS ultrasound score in an area of iodine deficiency
Background: In iodine-deficient region, thyroid nodules (TN) are more frequent and the proportion of benign nodules is higher compared to areas with sufficient iodine intake. Objective The aim of this study was to assess factors associated to malignant TN specially the Eu-TIRADS ultrasound score in a Moroccan population with high prevalence of iodine deficiency. Methods: In a prospective cross-sectional study, we enrolled outpatients referred for TN with Fine Needle Aspiration Biopsy (FNAB) indication according to EU-TIRADS 2017 classification. Malignancy of TN was defined by histological results indicating a thyroid malignancy on thyroid micro-biopsy or after surgical resection if indicated. Results: 225 TN were enrolled. The median of the patients’ age was 54 (42.5 ; 62) years-old. The prevalence of malignant TN was 8.9%. Malignant TN were significantly smaller than non-malignant ones (p = 0.008) and sub-centimetric TN were more frequent in malignant TN (25% vs 1.5%; p < 0.001). On multivariate analysis, male gender (OR : 9.33 ; 95% CI [2.02 ; 43.01]; p = 0,004) and EU-TIRADS 5 score (OR : 55.6 ; 95% CI [9.34 ; 327.91] ; p < 0.001) were independent factors associated with malignant TN. The EU-TIRADS 4 score was not associated to malignant TN. Conclusion Our data suggest a trend of over-diagnosing indolent thyroid cancer. The EU-TIRADS 4 score was not associated to TN malignancy. Considering clinical, accessory sonographic features and size threshold for FNAB in EU-TIRADS 4 score TN may refine the diagnosis performance of this score category in our population.
- 31 July 2024
- Published by University of Toronto Libraries - UOTL in University of Toronto Medical Journal
- Vol. 101 (2)
Open AccessPredicting malignancy of thyroid nodule using EU-TIRADS ultrasound score in an area of iodine deficiency
Background: In iodine-deficient region, thyroid nodules (TN) are more frequent and the proportion of benign nodules is higher compared to areas with sufficient iodine intake. Objective The aim of this study was to assess factors associated to malignant TN specially the Eu-TIRADS ultrasound score in a Moroccan population with high prevalence of iodine deficiency. Methods: In a prospective cross-sectional study, we enrolled outpatients referred for TN with Fine Needle Aspiration Biopsy (FNAB) indication according to EU-TIRADS 2017 classification. Malignancy of TN was defined by histological results indicating a thyroid malignancy on thyroid micro-biopsy or after surgical resection if indicated. Results: 225 TN were enrolled. The median of the patients’ age was 54 (42.5 ; 62) years-old. The prevalence of malignant TN was 8.9%. Malignant TN were significantly smaller than non-malignant ones (p = 0.008) and sub-centimetric TN were more frequent in malignant TN (25% vs 1.5%; p < 0.001). On multivariate analysis, male gender (OR : 9.33 ; 95% CI [2.02 ; 43.01]; p = 0,004) and EU-TIRADS 5 score (OR : 55.6 ; 95% CI [9.34 ; 327.91] ; p < 0.001) were independent factors associated with malignant TN. The EU-TIRADS 4 score was not associated to malignant TN. Conclusion Our data suggest a trend of over-diagnosing indolent thyroid cancer. The EU-TIRADS 4 score was not associated to TN malignancy. Considering clinical, accessory sonographic features and size threshold for FNAB in EU-TIRADS 4 score TN may refine the diagnosis performance of this score category in our population.
- 4 September 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (5) , 103931
Bacterial scleritis secondary to osteitis in a diabetic patient
- 4 September 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (5) , 103931
Bacterial scleritis secondary to osteitis in a diabetic patient
- 1 August 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 32 (4) , 192-195
Acute anterior uveitis under bisphosphonates: a serious complication to be aware of
- 1 August 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 32 (4) , 192-195
Acute anterior uveitis under bisphosphonates: a serious complication to be aware of
- 1 April 2021
- Published by Elmer Press, Inc. in Journal of Endocrinology and Metabolism
- Vol. 11 (2) , 52-55
An Unusual Complication of Cabergoline Treatment of Macroprolactinomas
Dopamine agonist (DA) treatment is the first choice treatment of prolactinomas. Optic chiasm prolapse with secondary visual deterioration is an unusual and rare complication of DA treatment. A 40-year-old man with giant prolactinoma was successfully treated by cabergoline. After 14 months, he presented with a visual impairment with no ophthalmologic anomalies that could explain this worsening. The pituitary magnetic resonance imaging (MRI) revealed an important shrinkage of prolactinoma with a prolapse and a central atrophy of optic chiasm secondary to the adenoma shrinkage. This case highlights the need of regular assessment of visual field all along cabergoline treatment of macroprolactinomas despite initial improvement or even normalization of visual field, to promptly identify an optic chiasm prolapse and avoid the optic chiasm atrophy. J Endocrinol Metab. 2021;11(2):52-55 doi: https://doi.org/10.14740/jem730
- 1 April 2021
- Published by Elmer Press, Inc. in Journal of Endocrinology and Metabolism
- Vol. 11 (2) , 52-55
An Unusual Complication of Cabergoline Treatment of Macroprolactinomas
Dopamine agonist (DA) treatment is the first choice treatment of prolactinomas. Optic chiasm prolapse with secondary visual deterioration is an unusual and rare complication of DA treatment. A 40-year-old man with giant prolactinoma was successfully treated by cabergoline. After 14 months, he presented with a visual impairment with no ophthalmologic anomalies that could explain this worsening. The pituitary magnetic resonance imaging (MRI) revealed an important shrinkage of prolactinoma with a prolapse and a central atrophy of optic chiasm secondary to the adenoma shrinkage. This case highlights the need of regular assessment of visual field all along cabergoline treatment of macroprolactinomas despite initial improvement or even normalization of visual field, to promptly identify an optic chiasm prolapse and avoid the optic chiasm atrophy. J Endocrinol Metab. 2021;11(2):52-55 doi: https://doi.org/10.14740/jem730
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 336
État de mal épileptique révélant une encéphalopathie d’Hashimoto : à propos d’un cas
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 336
État de mal épileptique révélant une encéphalopathie d’Hashimoto : à propos d’un cas
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 348
Piège diagnostic : carcinome papillaire développé sur une ectopie thyroïdienne latérocervicale
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 348
Piège diagnostic : carcinome papillaire développé sur une ectopie thyroïdienne latérocervicale
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 271
Syndrome d’Allgrove et sclérose latérale amyotrophique : maladie rare et association rarissime
- 1 September 2017
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 78 (4) , 271
Syndrome d’Allgrove et sclérose latérale amyotrophique : maladie rare et association rarissime
- 1 September 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (4) , 480
Syndrome de Prader-Willi : à propos d’un cas
- 1 September 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (4) , 480
Syndrome de Prader-Willi : à propos d’un cas
- 1 September 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (4) , 467
Désordres du développement sexuel 46,XY et cardiopathie congénitale : association syndromique ou simple coïncidence ?
- 1 September 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (4) , 467
Désordres du développement sexuel 46,XY et cardiopathie congénitale : association syndromique ou simple coïncidence ?
- 1 September 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (4) , 356
Association gliome malin de haut grade et adénome hypophysaire chez le même patient : à propos d’un cas
- 1 September 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (4) , 356
Association gliome malin de haut grade et adénome hypophysaire chez le même patient : à propos d’un cas